{"transactions":[{"id":1295784,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-01-24T21:10:44.000Z","date":"2025-01-23","kind":"exercise","planned":true,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 2, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was fully vested and exercisable as of June 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":131.21,"exercise_date":"2016-06-01","expiration_date":"2025-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001735276-25-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000002/edgardoc.xml","form_type":"4"}},{"id":1295783,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-24T21:10:44.000Z","date":"2025-01-23","kind":"sale","planned":true,"acquired":false,"shares":11250,"price":275,"value":3093750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 2, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-25-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000002/edgardoc.xml","form_type":"4"}},{"id":1295782,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-24T21:10:44.000Z","date":"2025-01-23","kind":"exercise","planned":true,"acquired":true,"shares":11250,"price":131.21,"value":1476112.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 2, 2024. The 11,250 options exercised and sold by the reporting person were due to expire on June 1, 2025."}],"balance_after":11250,"source":{"system":"sec-edgar","filing":"0001735276-25-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000002/edgardoc.xml","form_type":"4"}},{"id":1509300,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-05-20T20:02:28.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5228,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-24-000045","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000045/edgardoc.xml","form_type":"4"}},{"id":1607703,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."}],"balance_after":0,"derivative":{"exercise_price":59.25,"exercise_date":"2015-06-05","expiration_date":"2024-06-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607702,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":516,"price":156.54,"value":80774.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $156.15 to $156.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607701,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":101,"price":154.07,"value":15561.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $154.06 to $154.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":516,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607700,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":1906,"price":153.62,"value":292799.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $153.04 to $154.03. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":617,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607699,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":915,"price":152.4,"value":139446.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $152.02 to $152.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2523,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607698,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":13557,"price":151.43,"value":2052936.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $151.01 to $151.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3438,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607697,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":13005,"price":150.6,"value":1958553.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $150.00 to $151.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16995,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1607696,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:12:55.000Z","date":"2024-02-29","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":59.25,"value":1777500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001735276-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000022/edgardoc.xml","form_type":"4"}},{"id":1879790,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-24T18:35:55.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":12054,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12054,"derivative":{"exercise_price":25.74,"exercise_date":"2024-05-22","expiration_date":"2033-05-21","underlying":"Common Stock","underlying_shares":12054},"source":{"system":"sec-edgar","filing":"0001209191-23-031842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123031842/doc4.xml","form_type":"4"}},{"id":1879789,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T18:35:55.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":6027,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":121174,"source":{"system":"sec-edgar","filing":"0001209191-23-031842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123031842/doc4.xml","form_type":"4"}},{"id":1885129,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-05-19T20:03:04.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":3454,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-23-000059","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000059/edgardoc.xml","form_type":"4"}},{"id":2182309,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."}],"balance_after":0,"derivative":{"exercise_price":30.09,"exercise_date":"2014-06-06","expiration_date":"2023-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182308,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"exercise","acquired":false,"shares":3670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option was fully vested as of 12/31/14."}],"balance_after":0,"derivative":{"exercise_price":63.86,"expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":3670},"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182307,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":715,"price":232.81,"value":166459.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Sale prices ranged from $232.53 to $233.16."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182306,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":3853,"price":231.65,"value":892547.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices ranged from $231.31 to $232.26."}],"balance_after":715,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182305,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":16186,"price":230.71,"value":3734272.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices ranged from $230.30 to $231.30."}],"balance_after":4568,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182304,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":11600,"price":229.93,"value":2667188.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $229.29 to $230.29."}],"balance_after":20754,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182303,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":1218,"price":228.33,"value":278105.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $228.00 to $228.80."}],"balance_after":32354,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182302,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":98,"price":226.16,"value":22163.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."}],"balance_after":33572,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182301,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":3670,"price":63.86,"value":234366.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."}],"balance_after":33670,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2182300,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:07:02.000Z","date":"2022-08-15","kind":"exercise","acquired":true,"shares":30000,"price":30.09,"value":902700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001735276-22-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000069/edgardoc.xml","form_type":"4"}},{"id":2247143,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T19:08:34.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":0.78,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-033712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000120919122033712/doc4.xml","form_type":"4"}},{"id":2256822,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T22:12:15.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":12810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12810,"derivative":{"exercise_price":24.14,"exercise_date":"2023-05-23","expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":12810},"source":{"system":"sec-edgar","filing":"0001209191-22-031961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122031961/doc4.xml","form_type":"4"}},{"id":2256821,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T22:12:15.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":115147,"source":{"system":"sec-edgar","filing":"0001209191-22-031961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122031961/doc4.xml","form_type":"4"}},{"id":2262169,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-05-20T20:05:01.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5153,"derivative":{"exercise_price":128.31,"exercise_date":"2023-05-18","expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001735276-22-000048","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000048/edgardoc.xml","form_type":"4"}},{"id":2402109,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-02-11T21:04:06.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022."}],"balance_after":0,"derivative":{"exercise_price":11.33,"exercise_date":"2013-06-21","expiration_date":"2022-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001735276-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000014/edgardoc.xml","form_type":"4"}},{"id":2402108,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:04:06.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":30000,"price":150,"value":4500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000014/edgardoc.xml","form_type":"4"}},{"id":2402107,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-11T21:04:06.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":30000,"price":11.33,"value":339900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 30,000 options exercised and sold by the reporting person were due to expire on June 21, 2022."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001735276-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000014/edgardoc.xml","form_type":"4"}},{"id":2630792,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-19T20:18:57.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":4032,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-21-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527621000064/edgardoc.xml","form_type":"4"}},{"id":2673603,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-10T17:30:04.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":6.3,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-039578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000120919121039578/doc4.xml","form_type":"4"}},{"id":2697045,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-25T20:48:18.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":6748,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6748,"derivative":{"exercise_price":45.28,"exercise_date":"2022-05-21","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":6748},"source":{"system":"sec-edgar","filing":"0001209191-21-035716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121035716/doc4.xml","form_type":"4"}},{"id":2697044,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T20:48:18.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":3374,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108742,"source":{"system":"sec-edgar","filing":"0001209191-21-035716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121035716/doc4.xml","form_type":"4"}},{"id":2934995,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T21:01:12.000Z","date":"2020-12-07","kind":"gift","acquired":true,"shares":235633,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The 235,633 shares were previously reported as directly beneficially owned. On December 7, 2020, these shares were contributed to the \"Phillip A. Sharp Revocable Trust,\" of which the reporting person and his spouse are co-trustees."}],"balance_after":266899,"source":{"system":"sec-edgar","filing":"0001735276-20-000108","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000108/edgardoc.xml","form_type":"4"}},{"id":2934994,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T21:01:12.000Z","date":"2020-12-07","kind":"gift","acquired":false,"shares":235633,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-20-000108","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000108/edgardoc.xml","form_type":"4"}},{"id":2964432,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."}],"balance_after":0,"derivative":{"exercise_price":9.3,"exercise_date":"2012-06-09","expiration_date":"2021-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":2964431,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"sale","acquired":false,"shares":645,"price":127.44,"value":82198.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices ranged from $127.23 to $127.92."}],"balance_after":235633,"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":2964430,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"sale","acquired":false,"shares":2117,"price":126.16,"value":267080.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices ranged from $125.72 to $126.60."}],"balance_after":236278,"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":2964429,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"sale","acquired":false,"shares":15715,"price":125.05,"value":1965160.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $124.66 to $125.60."}],"balance_after":238395,"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":2964428,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"sale","acquired":false,"shares":11523,"price":124.3,"value":1432308.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $123.65 to $124.64."}],"balance_after":254110,"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":2964427,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-30T21:03:23.000Z","date":"2020-11-25","kind":"exercise","acquired":true,"shares":30000,"price":9.3,"value":279000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. The 30,000 options exercised and sold by the reporting person were due to expire on June 9, 2021."}],"balance_after":265633,"source":{"system":"sec-edgar","filing":"0001735276-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000105/edgardoc.xml","form_type":"4"}},{"id":3008352,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T23:15:29.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":24850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24850,"derivative":{"exercise_price":37.06,"exercise_date":"2021-05-21","expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":24850},"source":{"system":"sec-edgar","filing":"0001209191-20-054742","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120054742/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-26"}},{"id":3089167,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-07-06T20:51:19.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4581,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-20-000077","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000077/edgardoc.xml","form_type":"4"}},{"id":3113113,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T16:52:56.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":9.17,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-20-035968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000120919120035968/doc4.xml","form_type":"4"}},{"id":3135256,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T21:00:30.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":28888,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28888,"derivative":{"exercise_price":37.06,"exercise_date":"2021-05-21","expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":28888},"source":{"system":"sec-edgar","filing":"0001209191-20-032066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120032066/doc4.xml","form_type":"4"}},{"id":3274482,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-02-13T21:06:18.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":0,"derivative":{"exercise_price":15.82,"exercise_date":"2011-06-02","expiration_date":"2020-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001735276-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000016/edgardoc.xml","form_type":"4"}},{"id":3274481,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-02-13T21:06:18.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":0,"derivative":{"exercise_price":9.14,"exercise_date":"2011-12-08","expiration_date":"2020-12-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001735276-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000016/edgardoc.xml","form_type":"4"}},{"id":3274480,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T21:06:18.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":30000,"price":130,"value":3900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":235633,"source":{"system":"sec-edgar","filing":"0001735276-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000016/edgardoc.xml","form_type":"4"}},{"id":3274479,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T21:06:18.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":15000,"price":9.14,"value":137100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":265633,"source":{"system":"sec-edgar","filing":"0001735276-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000016/edgardoc.xml","form_type":"4"}},{"id":3274478,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-13T21:06:18.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":15000,"price":15.82,"value":237300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":250633,"source":{"system":"sec-edgar","filing":"0001735276-20-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000016/edgardoc.xml","form_type":"4"}},{"id":3364417,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-11-20T21:17:22.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019."}],"balance_after":0,"derivative":{"exercise_price":16.43,"exercise_date":"2010-12-10","expiration_date":"2019-12-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001735276-19-000096","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000096/edgardoc.xml","form_type":"4"}},{"id":3364416,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-20T21:17:22.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":810,"price":92.66,"value":75054.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices ranged from $92.53 to $92.74."}],"balance_after":235633,"source":{"system":"sec-edgar","filing":"0001735276-19-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000096/edgardoc.xml","form_type":"4"}},{"id":3364415,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-20T21:17:22.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":8631,"price":91.97,"value":793793.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $91.50 to $92.48."}],"balance_after":236443,"source":{"system":"sec-edgar","filing":"0001735276-19-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000096/edgardoc.xml","form_type":"4"}},{"id":3364414,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-20T21:17:22.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":5559,"price":91.17,"value":506814.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $90.50 to $91.49."}],"balance_after":245074,"source":{"system":"sec-edgar","filing":"0001735276-19-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000096/edgardoc.xml","form_type":"4"}},{"id":3364413,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-20T21:17:22.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":15000,"price":16.43,"value":246450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019. The 15,000 options exercised and sold by the reporting person were due to expire on December 9, 2019."}],"balance_after":250633,"source":{"system":"sec-edgar","filing":"0001735276-19-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000096/edgardoc.xml","form_type":"4"}},{"id":3391050,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44444},"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391049,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44444},"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391048,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44444},"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391047,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":88888,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":88888},"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391046,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391045,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391044,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":44444,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee."}],"balance_after":44444,"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3391043,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-18T23:53:28.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":88888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Convertible Preferred Stock (the \"Preferred Stock\") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."}],"balance_after":105368,"source":{"system":"sec-edgar","filing":"0001209191-19-053663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053663/doc4.xml","form_type":"4"}},{"id":3394361,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILLIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-11T23:43:23.000Z","date":"2019-10-10","kind":"grant","acquired":true,"shares":22222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the stock option vest and become exercisable on October 10, 2020, and the remainder vest in 24 equal monthly installments thereafter."}],"balance_after":22222,"derivative":{"exercise_price":20,"expiration_date":"2029-10-10","underlying":"Common Stock","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001209191-19-053067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119053067/doc4.xml","form_type":"4"}},{"id":3471572,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-07-02T20:07:27.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-19-000067","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000067/edgardoc.xml","form_type":"4"}},{"id":3492434,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T16:16:58.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":11000,"derivative":{"exercise_price":5.6,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-19-036365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000120919119036365/doc4.xml","form_type":"4"}},{"id":3554051,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."}],"balance_after":0,"derivative":{"exercise_price":22.09,"exercise_date":"2010-06-11","expiration_date":"2019-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3554050,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":600,"price":91.4,"value":54840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices ranged from $91.00 to $91.86."}],"balance_after":235633,"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3554049,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":400,"price":89.97,"value":35988.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices ranged from $89.56 to $90.13."}],"balance_after":236233,"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3554048,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":2200,"price":89.03,"value":195866.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $88.49 to $89.43."}],"balance_after":236633,"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3554047,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":11800,"price":87.86,"value":1036748.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $87.48 to $88.43."}],"balance_after":238833,"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3554046,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:05:50.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":15000,"price":22.09,"value":331350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018."}],"balance_after":250633,"source":{"system":"sec-edgar","filing":"0001735276-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000037/edgardoc.xml","form_type":"4"}},{"id":3885272,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-06-22T20:20:15.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":105.26,"exercise_date":"2019-06-20","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-18-000034","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527618000034/edgardoc.xml","form_type":"4"}},{"id":3892217,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T16:29:50.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":11000,"derivative":{"exercise_price":12.95,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-18-008623","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000117911018008623/edgar.xml","form_type":"4"}},{"id":3996517,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-14T23:39:57.000Z","date":"2018-03-13","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":21.35,"exercise_date":"2009-12-09","expiration_date":"2018-12-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001553878-18-000021","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000021/edgardoc.xml","form_type":"4"}},{"id":3996516,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T23:39:57.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":15000,"price":149,"value":2235000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":140795,"source":{"system":"sec-edgar","filing":"0001553878-18-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000021/edgardoc.xml","form_type":"4"}},{"id":3996515,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-14T23:39:57.000Z","date":"2018-03-13","kind":"exercise","acquired":true,"shares":15000,"price":21.35,"value":320250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":155795,"source":{"system":"sec-edgar","filing":"0001553878-18-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387818000021/edgardoc.xml","form_type":"4"}},{"id":3998617,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-03-13T21:22:03.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":27.28,"exercise_date":"2009-06-03","expiration_date":"2018-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001325812-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000132581218000020/edgardoc.xml","form_type":"4"}},{"id":3998616,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T21:22:03.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":15000,"price":129,"value":1935000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":140795,"source":{"system":"sec-edgar","filing":"0001325812-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000132581218000020/edgardoc.xml","form_type":"4"}},{"id":3998615,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-13T21:22:03.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":15000,"price":27.28,"value":409200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 10, 2017."}],"balance_after":155795,"source":{"system":"sec-edgar","filing":"0001325812-18-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000132581218000020/edgardoc.xml","form_type":"4"}},{"id":4203029,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-22T17:20:20.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This amendment to the Statement of Changes in Beneficial Ownership of Securities on Form 4 filed with the Securities and Exchange Commission on June 12, 2017 is being filed to correct a typographical error in the exercise price of the option to purchase Common Stock held by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the award, with the remainder vesting in equal monthly installments until the first anniversary of the date of the award, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":11000,"derivative":{"exercise_price":14.62,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-17-012631","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000117911017012631/edgar.xml","form_type":"4/A","original_submission_date":"2017-06-12"}},{"id":4285265,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-12T16:02:52.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the award, with the remainder vesting in equal monthly installments until the first anniversary of the date of the award, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":11000,"derivative":{"exercise_price":14.26,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-17-008895","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000117911017008895/edgar.xml","form_type":"4"}},{"id":4291303,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-06-06T21:02:42.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11250,"derivative":{"exercise_price":71.99,"exercise_date":"2018-06-02","expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001553878-17-000033","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000033/edgardoc.xml","form_type":"4"}},{"id":4468847,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-02-03T21:32:58.000Z","date":"2017-02-01","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":0,"derivative":{"exercise_price":31.29,"exercise_date":"2008-12-12","expiration_date":"2017-12-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001553878-17-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000009/edgardoc.xml","form_type":"4"}},{"id":4468846,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-03T21:32:58.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":4829,"price":40.16,"value":193932.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $40.10 to $40.24"}],"balance_after":140795,"source":{"system":"sec-edgar","filing":"0001553878-17-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000009/edgardoc.xml","form_type":"4"}},{"id":4468845,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-03T21:32:58.000Z","date":"2017-02-01","kind":"sale","acquired":false,"shares":20171,"price":39.72,"value":801192.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $39.09 to $40.08"}],"balance_after":145624,"source":{"system":"sec-edgar","filing":"0001553878-17-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000009/edgardoc.xml","form_type":"4"}},{"id":4468844,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-03T21:32:58.000Z","date":"2017-02-01","kind":"exercise","acquired":true,"shares":25000,"price":31.29,"value":782250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":165795,"source":{"system":"sec-edgar","filing":"0001553878-17-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000009/edgardoc.xml","form_type":"4"}},{"id":4479331,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-01-27T21:10:04.000Z","date":"2017-01-25","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":0,"derivative":{"exercise_price":31.39,"exercise_date":"2008-12-12","expiration_date":"2017-12-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001553878-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000007/edgardoc.xml","form_type":"4"}},{"id":4479330,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-27T21:10:04.000Z","date":"2017-01-25","kind":"sale","acquired":false,"shares":15000,"price":37.95,"value":569250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $37.31 to $38.25"}],"balance_after":140795,"source":{"system":"sec-edgar","filing":"0001553878-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000007/edgardoc.xml","form_type":"4"}},{"id":4479329,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-27T21:10:04.000Z","date":"2017-01-25","kind":"exercise","acquired":true,"shares":15000,"price":31.39,"value":470850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":155795,"source":{"system":"sec-edgar","filing":"0001553878-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000007/edgardoc.xml","form_type":"4"}},{"id":4485323,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-01-20T21:12:57.000Z","date":"2017-01-18","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":0,"derivative":{"exercise_price":15.91,"exercise_date":"2008-06-01","expiration_date":"2017-06-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001553878-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000004/edgardoc.xml","form_type":"4"}},{"id":4485322,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T21:12:57.000Z","date":"2017-01-18","kind":"sale","acquired":false,"shares":6200,"price":38.2,"value":236840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices ranged from $38.09 to $38.50"}],"balance_after":140795,"source":{"system":"sec-edgar","filing":"0001553878-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000004/edgardoc.xml","form_type":"4"}},{"id":4485321,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T21:12:57.000Z","date":"2017-01-18","kind":"sale","acquired":false,"shares":8800,"price":37.57,"value":330616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices ranged from $37.07 to $38.06"}],"balance_after":146995,"source":{"system":"sec-edgar","filing":"0001553878-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000004/edgardoc.xml","form_type":"4"}},{"id":4485320,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T21:12:57.000Z","date":"2017-01-18","kind":"exercise","acquired":true,"shares":15000,"price":15.91,"value":238650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2016."}],"balance_after":155795,"source":{"system":"sec-edgar","filing":"0001553878-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000155387817000004/edgardoc.xml","form_type":"4"}},{"id":4599801,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":83914,"kind":"person","name":"SHARP PHILLIP A","position":1,"cik":"0001226295","reported_name":"SHARP PHILIP A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-09-19T06:56:36.000Z","date":"2016-09-15","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the award, with the remainder vesting in equal monthly installments of 2.77% of the shares underlying the award until the third anniversary of the date of the award, subject to Dr. Sharp's continued service as a director through each applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":12.59,"expiration_date":"2026-09-14","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-16-145304","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226295/000110465916145304/a4.xml","form_type":"4"}}]}